Skip to main content
Equibles
DH logo

DH · Definitive Healthcare Corp.

Track DH — free

Use DH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about DH

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.64 0.00 (-0.23%) At close · Aug 14
Market Cap
$68.23M
Shares
106.74M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.64 Open$0.63 Day$0.61–0.65 52W close$0.63–4.30 Avg vol 30d229K Short int2.0M · 1.8% float · 12.1d Short vol41% Last earningsAug 10, 2026 DataSep 2021–Aug 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Nov 11, 2026 Est · unconfirmed · in 13 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 10, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Strong Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −58%
      below
      Price vs 50-day avg −16%
      below
      RSI (14) 38
      neutral
      MACD trend Negative
      52-week position 0%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −16%
      trailing
      6-month return −54%
      trailing
      YTD return −78%
      this year
      Relative strength −67%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $1 › 200d $2 — 200d above 50d
      Institutional flow Distributing
      -17% holders QoQ · +18 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      1.84% of float · ▼ -3.6% MoM · 12.1 days cover
      Volume signal Reversal watch
      High volume on a down day — possible exhaustion
      Institution breadth Multi-yr low
      99 holders — near 3-yr low, contrarian setup
      Squeeze score 52
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth −4%
      Y/Y
      Gross margin 76%
      contracting
      EPS growth +63%
      Y/Y
      Free cash flow $37.1M
      Buyback $120.0M
      authorized
      Balance sheet $1.2M
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 72%
      annualized · 1-yr
      Max drawdown −85%
      past year
      ATR 8.6%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 4 of last 5
      Latest guidance · from the 8-K filed Aug 10, 2026
      Third Quarter 2026
      Revenue $54M – $55M
      Adjusted Operating Income Non-GAAP $10.5M – $11.5M
      Adjusted EBITDA Margin Non-GAAP 25% – 27%
      Adjusted Net Income Non-GAAP $5.5M – $6.5M
      Adjusted EBITDA Non-GAAP $13.5M – $14.5M
      Adjusted Net Income Per Diluted Share Non-GAAP $0.04 – $0.05
      Full Year 2026
      Revenue $220M – $222M
      Adjusted Operating Income Non-GAAP $45.5M – $47.5M
      Adjusted Net Income Non-GAAP $27M – $29M
      Adjusted EBITDA Margin Non-GAAP 26% – 27%
      Adjusted Net Income Per Diluted Share Non-GAAP $0.18 – $0.20
      Adjusted EBITDA Non-GAAP $57M – $59M
      Prior guidance period ended · from the 8-K filed May 7, 2026
      Revenue · Second Quarter 2026 $55M – $56M
      Adjusted Operating Income · Second Quarter 2026 $10.5M – $11.5M
      Adjusted EBITDA · Second Quarter 2026 $13.5M – $14.5M
      Adjusted Net Income · Second Quarter 2026 $5M – $6M
      Adjusted Net Income Per Diluted Share · Second Quarter 2026 $0.03 – $0.04
      Guided vs delivered · last 5 settled
      Revenue Fourth Quarter 2025
      guided $59M – $60M
      $61.53M Beat +3.4%
      Revenue Full Year 2025
      guided $239M – $240M
      $241.52M Beat +0.8%
      Total revenue Q2
      guided $62M – $63.5M
      $63.74M Beat +1.6%
      Revenue full year 2024
      guided $255M – $261M
      $252.2M Miss −2.2%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Sell
      4 · 3 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −58% Bearish
      Price vs 50-day avg
      −16% Bearish
      RSI (14)
      38 Neutral
      MACD trend
      Negative Bearish
      52-week position
      0% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $1 › 200d $2 — 200d above 50d
      Institutional flow Distributing
      -17% holders QoQ · +18 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      1.84% of float · ▼ -3.6% MoM · 12.1 days cover
      Volume signal Reversal watch
      High volume on a down day — possible exhaustion
      Institution breadth Multi-yr low
      99 holders — near 3-yr low, contrarian setup
      Price context
      position in its 52-week range
      Range low $1 Now $1 · 0% Range high $4
      vs 200-day avg -58% vs 50-day avg -16%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted Gross Margin non-GAAP 80% Six Months Ended June 30, 2026 —
      Adjusted Gross Profit non-GAAP 89.38M Six Months Ended June 30, 2026 —
      Adjusted Net Income Per Share non-GAAP $0.11 Six Months Ended June 30, 2026 —
      Adjusted Operating Income non-GAAP 24.73M Six Months Ended June 30, 2026 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Health Information Services — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      DH
      Definitive Healthcare Corp.
      this stock
      		$68.23M -77.7% -4.2% — 1.8%
      VEEV
      Veeva Systems Inc
      		 $39.23B +9.2% +28.1% 42.8 4.5%
      PMDIY
      Pro Medicus Ltd./ADR
      		 $15.41B -18.8% — — 0.0%
      BTSG
      BrightSpring Health Services, Inc.
      		 $12.21B +64.8% +28.2% 37.4 4.2%
      TEM
      Tempus AI, Inc.
      		 $9.85B -11.8% +83.4% — 18.4%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      99
      % held
      81.2%
      Net QoQ
      -2.1M sh
      Top holder
      Advent International, L.P.
      Held Float
      View
      Held by Funds
      Fund positions
      142
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      2.0M
      Days to cover
      12.1d
      Change
      -74.5K sh
      View
      Short Volume
      Short vol %
      41%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      2.0K
      Value
      $1.7K
      As of
      Jun 10, 2026
      View
      Off-Exchange
      Off-exchange %
      51.6%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $241.5M
      Net income (FY)
      $-138.9M
      EPS diluted
      $-1.30
      View
      Buybacks
      Authorized · 2 programs
      $120.0M
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 10, 2026
      This year
      11
      View
      Proposed Sales
      Value
      $209.3K
      Shares
      45.0K
      Filed
      Dec 3, 2024
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 10, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      DH -10.5% -15.8% -53.7% -6.3% -77.7%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -10.9% -20.2% -67.5% -10.2% -91.6%

      Capital returns

      Buyback programs · 2 active · as of Nov 1, 2024
      Authorized (total)
      $120.00M
      Spent (derived)
      —
      Remaining
      —

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1861795 CUSIP 24477E103 13F (30d) 96 filings 96 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)